These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10147131)

  • 1. Breast cancer: clinical decision making.
    Hayes JD; Clark EJ
    Pharmacoeconomics; 1993 Sep; 4(3):226-8. PubMed ID: 10147131
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and cost-effectiveness of autologous bone marrow transplantation in metastatic breast cancer. Estimates using decision analysis while awaiting clinical trial results.
    Hillner BE; Smith TJ; Desch CE
    JAMA; 1992 Apr; 267(15):2055-61. PubMed ID: 1552641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical decision making vs programme evaluation perspectives.
    Levine MN; Gafni A
    Pharmacoeconomics; 1993 Sep; 4(3):228-31. PubMed ID: 10147132
    [No Abstract]   [Full Text] [Related]  

  • 4. Health insurance: coverage of autologous bone marrow transplantation for breast cancer.
    Jaggar SF
    Oncology (Williston Park); 1996 Sep; 10(9):1329-32, 1337-8, 1340 passim. PubMed ID: 8882925
    [No Abstract]   [Full Text] [Related]  

  • 5. ABMT and breast cancer.
    Firshein J
    Healthplan; 1999; 40(4):30-3, 35-7. PubMed ID: 10557735
    [No Abstract]   [Full Text] [Related]  

  • 6. Variation in approval by insurance companies of coverage for autologous bone marrow transplantation for breast cancer.
    Peters WP; Rogers MC
    N Engl J Med; 1994 Feb; 330(7):473-7. PubMed ID: 8289855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) for the treatment of breast cancer: the jury is still out.
    Smith GA; Henderson IC
    Important Adv Oncol; 1995; ():201-14. PubMed ID: 7672807
    [No Abstract]   [Full Text] [Related]  

  • 8. Variations in insurance coverage for autologous bone marrow transplantation for breast cancer.
    Krause KJ
    N Engl J Med; 1994 Aug; 331(5):329; author reply 330-1. PubMed ID: 8068113
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of bone marrow transplantation in the management of advanced local disease.
    Safah H; Weiner RS
    Surg Oncol Clin N Am; 1995 Oct; 4(4):735-49. PubMed ID: 8535908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Last chance therapies and managed care. Pluralism, fair procedures, and legitimacy.
    Daniels N; Sabin JE
    Hastings Cent Rep; 1998; 28(2):27-41. PubMed ID: 9589291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using the 21-gene assay to guide adjuvant chemotherapy decision-making in early-stage breast cancer: a cost-effectiveness evaluation in the German setting.
    Blohmer JU; Rezai M; Kümmel S; Kühn T; Warm M; Friedrichs K; Benkow A; Valentine WJ; Eiermann W
    J Med Econ; 2013; 16(1):30-40. PubMed ID: 22966753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives. Indefinite results in ABMT (autologous bone marrow transplantation) trials add to challenges for practice standards, quality assurance in cancer care.
    Cunningham R
    Med Health; 1999 Apr; 53(16):suppl 1-4. PubMed ID: 10387749
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effective use of autologous bone marrow transplantation: few answers, many questions, and suggestions for future assessments.
    Hillner BE; Smith TJ; Desch CE
    Pharmacoeconomics; 1994 Aug; 6(2):114-26. PubMed ID: 10147437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mandates for unproven health care interventions.
    Gervais KG; Priester R
    Minn Med; 1996 Apr; 79(4):52-5. PubMed ID: 8637495
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of autologous bone marrow transplants as treatment for breast cancer.
    Uzych L
    J Am Med Womens Assoc (1972); 1992; 47(1):3. PubMed ID: 1545106
    [No Abstract]   [Full Text] [Related]  

  • 16. Women flock to ABMT for breast cancer without final proof.
    Smigel K
    J Natl Cancer Inst; 1995 Jul; 87(13):952-5. PubMed ID: 7629880
    [No Abstract]   [Full Text] [Related]  

  • 17. Peripheral blood stem cell transplant in breast cancer.
    Crilley P; Goldstein LJ
    Semin Oncol; 1995 Jun; 22(3):238-49. PubMed ID: 7777868
    [No Abstract]   [Full Text] [Related]  

  • 18. Variations in insurance coverage for autologous bone marrow transplantation for breast cancer.
    Cutler CM; Udvarhelyi IS; Winkenwerder W
    N Engl J Med; 1994 Aug; 331(5):329-30. PubMed ID: 8022449
    [No Abstract]   [Full Text] [Related]  

  • 19. How one company decides when to pay for experimental therapies.
    Oncology (Williston Park); 1995 Jul; 9(7):666. PubMed ID: 8924376
    [No Abstract]   [Full Text] [Related]  

  • 20. New approach to administrative medical decision-making: evidence-based medicine using high dose chemotherapy/bone marrow transplant for breast cancer.
    Lucey C; Westphal JR
    South Med J; 1998 Feb; 91(2):196-201. PubMed ID: 9496875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.